| Price | Rs 50.80 |
| ZEME fair value | Rs 34.72 |
| Discount to fair value | -31.7% |
| Smart-money phase | Fully Loaded |
| Confidence score | 34/100 |
| RSI (14) | 44.2 |
| P/E | 20.8 |
| ROE | —% |
| Dividend yield | —% |
| 52-week range | Rs 37.33 – Rs 80.28 |
| Sector | Pharmaceuticals |
| Shariah-compliant | Yes ☪ |
IBLHL (IBL Healthcare Limited) trades at Rs 50.80 on the Pakistan Stock Exchange, in the Fully Loaded smart-money phase — accumulated. ZEME's model puts fair value near Rs 34.72, making it about 31.7% overvalued. Smart money has fully loaded the position — a mature bullish setup, often before a markup.
ZEME AI reads IBLHL through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.
Constructive — ZEME sees smart-money accumulation; check the entry vs the load zone. Smart money has fully loaded the position — a mature bullish setup, often before a markup. As of 20 Jul 2026, IBLHL is in the Fully Loaded phase with a ZEME confidence score of 34/100.
ZEME estimates IBLHL's fair value at about Rs 34.72, versus a market price of Rs 50.80 — roughly 31.7% overvalued.
IBLHL is currently in the Fully Loaded phase. Smart money has fully loaded the position — a mature bullish setup, often before a markup.
Data updated 20 Jul 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.